Science News from the American Heart Association

 
We turn American Heart Association's Science News into an interactive format for you. Find something interesting or have a question? Let us know in the comments.

Science News From Emerging Science™ Series - April 25, 2012

ESS Banner

Protecting Cerebrovascular Function - From Translational Science to Clinical Trials
Wednesday, April 25, 2012, 12:00 noon - 1:05 pm

Moderators: 
  • Elliott Antman
  • Robert Harrington
  • Robert Bonow
Panelists:
  • John Murkin
  • Jeffrey Weitz 
  • Mark Clay   

ESS12_Pslides_Piccini_image

     		 Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial
Presenter: Jonathan P. Piccini, Duke Clinical Research Institute, Duke University Medical Center, Durham, N.C.


ESS12_Pslides_Easley_image      Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery  
Presenter: Ronald B. Easley, Baylor College of Medicine, Houston, Texas 

Posted by Stacy AHA Science on Apr 25, 2012 11:28 AM US/Central

Comment Using Social Media - Facebook, Yahoo, Hotmail

on http://networking.americanheart.org/blogs/6/396

Login or Join

You must be logged in to comment on blogs.

Login using your My.AmericanHeart credentials:


Don't have an account?


Login to Post

You must be logged in to comment on blogs.

Login using your My.AmericanHeart credentials:


Don't have an account?

Blog Tags

Search Blogs